It’s nearly time for championship week! We’re done looking forward; instead, we're and looking at which players can help us right now. Recent weeks have brought forth some big repeat performances from ...
SABCS and ASH findings: palbociclib improves PFS in HR+, HER2+ breast cancer, cilta-cel achieves 100% CR in smoldering MM, and selinexor with ruxolitinib aids myelofibrosis.